Default company panoramic image
F9393148 2c6c 48c0 bc46 4b600ce82846

Cavendish NanoTherapeutics

Cavendish NanoTherapeutics offers medical systems aimed at increasing the efficacy of chemotherapy/radiotherapy by targeting solid tumours.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Cambridge, England, GB
  • Currency GBP
  • Founded July 2011
  • Employees 2
  • Website cnt.uk.com

Company Summary

Cavendish NanoTherapeutics (CNT) offers advanced medical systems aimed at increasing the efficacy of chemotherapy or radiotherapy by targeting solid cancer tumours. CNT’s protocols enable a totally non-invasive approach that is given as an adjunct treatment to standard cancer therapies and is easily integrated with current clinical practices. CNT’s systems are based on magnetic nanotechnology and mild, non-ionising electromagnetic irradiation.

Team

  • Default avatar
    Thanos Mitrelias
    Dr

    Dr Mitrelias has 14 years of entrepreneurial and scientific activity. In 2008 he established Cambridge BioMagnetics to commercialise a disruptive technology for clinical diagnostics and the oil and gas industries. He has been at the Un. of Cambridge since 1994, has raised more than $5.5 million for business and scientific projects and has wide scientific and commercial expertise in biotechnology and nanoscience. Previous entrepreneurial activitie

  • Default avatar
    Marina Tselepi
    Dr

    Dr Tselepi is an experienced academic with a track record in project management. Her work in solid state physics and biomagnetism is internationally recognized and she has an extensive publications record including a patent. For the last 15 years she has been at the Cavendish Laboratory, University of Cambridge from where she obtained her PhD in Physics.

  • Default avatar
    Valerii Orel
    Professor

    Prof. Orel has been working in the development of targeted cancer treatments for more than 30 years. He directs a large research team at the National Cancer Institute, Kiev, Ukraine and has introduced state of the art treatments in clinical practice in Ukraine.

  • Default avatar
    Sergiy Litvinenko
    Dr

    Director of Radmir, a leading company in the production of advanced medical systems based in Kharkov, Ukraine.

Advisors

  • Default avatar
    Robert Matthews
    Lawyer
    Unconfirmed
    Default avatar
    Staffords Accountants
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    the founders
    Unconfirmed